Relates to the availability of buprenorphine in opioid treatment programs
Summary
Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.
Bill status
passed
3 of 5 stages cleared
Introduction
May 2021
Committee Review
May 2022
Senate Passage
May 2022
Assembly Passage
Governor
Introduced May 13, 2021
Last action May 25, 2022
Floor votes · Senate May 25, 2022
How they voted
59–0
Passed · 2 other
Total votes 61
May 25, 2022
D
Democratic42
95% Yea
R
Republican19
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
10
Key actions
3
Committee
3
Amendments
2
May 25, 2022
Committee
REFERRED TO WAYS AND MEANS
lower
May 25, 2022
Upper · Passed
PASSED SENATE
upper
Apr 27, 2022
Upper · Passed
PRINT NUMBER 6746A
upper
Apr 27, 2022
Upper · Passed
AMEND AND RECOMMIT TO ALCOHOLISM AND SUBSTANCE ABUSE
upper
Jan 5, 2022
Committee
REFERRED TO ALCOHOLISM AND SUBSTANCE ABUSE
upper
May 13, 2021
Committee
REFERRED TO ALCOHOLISM AND SUBSTANCE ABUSE
upper
1 primary · 1 co-sponsor
Sponsors
Role
Legislator
Party
State
District
P
Pete Harckham
DDemocratic/Working Families
Co
FA
Fred Akshar
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 6746
Scope: NY
Hi! I can help you understand S 6746. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline